A Case Report of Percutaneous Right Ventricular Assist Device Utilization After Cesarean Delivery in a Patient With Severe Pulmonary Arterial Hypertension

Caroline Thomas; Daniel Tobes; Kristin Trela; Mariana Montes; Candice Cuppini; Kyle Petty; Gurjit Saini; Joana Perdigao; Tae Song; Allison Dalton; Avery Tung

doi:10.1213/XAA.0000000000001728

A Case Report of Percutaneous Right Ventricular Assist Device Utilization After Cesarean Delivery in a Patient With Severe Pulmonary Arterial Hypertension

A A Pract. 2023 Nov 17;17(11):e01728. doi: 10.1213/XAA.0000000000001728. eCollection 2023 Nov 1.

Authors

Affiliations

¹ From the Department of Anesthesia and Critical Care, University of Chicago, Chicago, Illinois.
² Department of Maternal and Fetal Medicine, University of Chicago, Chicago, Illinois.
³ Department of Cardiac Surgery, University of Chicago, Chicago, Illinois.

PMID: 37975893
DOI: 10.1213/XAA.0000000000001728

Abstract

Physiologic changes of pregnancy are poorly tolerated in patients with pulmonary arterial hypertension (PAH), and peripartum maternal mortality is high. We present a case of a 31-year-old G3P0020 patient at 35 weeks' gestation with severe World Health Organization group I PAH who underwent cesarean delivery followed by percutaneous right ventricular assist device placement. Risks and benefits of the mode of delivery, neuraxial versus general anesthesia, and mechanical circulatory support are reviewed.

Publication types

Case Reports

MeSH terms

Adult
Cesarean Section
Familial Primary Pulmonary Hypertension
Female
Heart-Assist Devices*
Humans
Hypertension, Pulmonary* / therapy
Pregnancy
Pulmonary Arterial Hypertension* / therapy